Nominations Open for 2007 Pezcoller Foundation-AACR International Award for Cancer Research
July 17, 2006
Field(s) of Research
: Carcinogenesis, Cellular and Molecular Biology, Chemistry, Clinical Research, Endocrinology, Epidemiology, Experimental and Molecular Therapeutics, Immunology, Prevention Research, Tumor Biology
Nomination Deadline: Friday, September 15, 2006
PHILADELPHIA – Scientists involved in cancer research, cancer medicine, or cancer-related biomedical science can nominate a colleague or professional associate for the 10th Pezcoller Foundation-AACR International Award for Cancer Research. The award was established in 1997 to annually recognize a scientist:
- who has made a major scientific discovery in basic cancer research or who has made significant contributions to translational cancer research;
- who continues to be active in cancer research and has a record of recent, noteworthy publications; and
- whose ongoing work holds promise for continued substantive contributions to progress in the field of cancer.
While intended to honor an individual, more than one scientist may be co-nominated and selected to share the award when their investigations are closely related in subject matter.
The Award consists of €75,000 and a commemorative plaque. The winner also will give an award lecture during the 98th AACR Annual Meeting in Los Angeles, Calif., April 14-18, 2007, and will officially receive the award of €75,000 at a May 2007 ceremony in Trento, Italy, where the Pezcoller Foundation is located.
For more information on the nomination process and other details about the award, please click here. Inquiries regarding this award should be directed to firstname.lastname@example.org.
# # # #
The mission of the American Association for Cancer Research is to prevent and cure cancer. Founded in 1907, AACR is the world’s oldest and largest professional organization dedicated to advancing cancer research. The membership includes more than 24,000 basic, translational, and clinical researchers; health care professionals; and cancer survivors and advocates in the United States and more than 60 other countries. AACR marshals the full spectrum of expertise from the cancer community to accelerate progress in the prevention, diagnosis and treatment of cancer through high-quality scientific and educational programs. It funds innovative, meritorious research grants. The AACR Annual Meeting attracts over 17,000 participants who share the latest discoveries and developments in the field. Special Conferences throughout the year present novel data across a wide variety of topics in cancer research, treatment, and patient care. AACR publishes five major peer-reviewed journals: Cancer Research; Clinical Cancer Research; Molecular Cancer Therapeutics; Molecular Cancer Research; and Cancer Epidemiology, Biomarkers & Prevention. AACR’s most recent publication, CR, is a magazine for cancer survivors, patient advocates, their families, physicians, and scientists. It provides a forum for sharing essential, evidence-based information and perspectives on progress in cancer research, survivorship, and advocacy.
215-440-9300 ext. 101
215-440-9300 ext. 114